Toggle navigation
About
Approach
Team
Companies
News Room
Contact
Aldena Therapeutics Accelerates its Novel and Disruptive Approach to Immuno-Dermatology
Press Release
Incyte Announces Agreement to Acquire Medicxi-backed Villaris Therapeutics and Auremolimab (VM6), an Anti-IL-15Rβ Monoclonal Antibody
Press Release
Medicxi portfolio company MiroBio to be acquired by Gilead Sciences for approximately $405 million
Press Release
Phathom Pharmaceuticals Announces FDA Approval of VOQUEZNA™ TRIPLE PAK™ (vonoprazan, amoxicillin, clarithromycin) and VOQUEZNA™ DUAL PAK™ (vonoprazan, amoxicillin)
Press Release
Rivus Pharmaceuticals Announces Positive Data from Phase 2a Clinical Trial of Lead Candidate HU6, Demonstrating Fat Reduction and Weight Loss in High BMI Participants
Press Release
Centessa Announces Pricing of Initial Public Offering
Press Release
